Precision medicine, propelled by advances in multi-omics methods and analytics, aims to revolutionize patient care by using clinically-actionable molecular markers to guide diagnostic and therapeutic decisions. We describe the applications of precision medicine in risk stratification, drug selection, and treatment response prediction in psoriatic arthritis, for which targeted, personalized approaches are steadily emerging.
Keywords: Genomics; Microbiome; Multi-omics; Personalized medicine; Precision medicine; Proteomics; Psoriasis; Psoriatic arthritis; Seronegative spondyloarthritis; Transcriptomics.
Copyright © 2020. Published by Elsevier Inc.